Literature DB >> 11324686

Genetic and immunological basis of autoimmune diabetes in the NOD mouse.

K Yoshida1, H Kikutani.   

Abstract

The non-obese diabetic (NOD) mouse is an animal model of human insulin-dependent diabetes mellitus (IDDM). Most NOD mice show insulitis at several weeks of age, and 60-90% of the female mice develop overt diabetes after 20-30 weeks of age. NOD mice share many features of human IDDM. As in human IDDM, the disease development in NOD mice is controlled by a number of disease susceptibility or resistant genes (Idds), including the major histocompatibility complex locus. Cumulative evidence suggests that Thl CD4+ T cells play a critical role in the autoimmune process leading to beta cell destruction. In addition to CD4+ T cells, CD8+ cells and B cells also participate in the pathogenesis. There are several candidate antigens recognized by autoreactive T cells such as glutamic acid decarboxylase (GAD), insulin and heat shock protein (HSP) 60. Treatment by these antigens suppresses IDDM development in NOD mice, suggesting that they may initiate the autoimmune process of NOD mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11324686

Source DB:  PubMed          Journal:  Rev Immunogenet        ISSN: 1398-1714


  12 in total

Review 1.  Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.

Authors:  Frank Waldron-Lynch; Kevan C Herold
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 2.  Metabolic regulation of inflammasomes in inflammation.

Authors:  Qiuli Yang; Ruichen Liu; Qing Yu; Yujing Bi; Guangwei Liu
Journal:  Immunology       Date:  2019-04-08       Impact factor: 7.397

Review 3.  Inflammasomes and autoimmunity.

Authors:  Patrick J Shaw; Michael F McDermott; Thirumala-Devi Kanneganti
Journal:  Trends Mol Med       Date:  2010-12-14       Impact factor: 11.951

4.  Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice.

Authors:  Zhuo Fu; Wei Zhen; Julia Yuskavage; Dongmin Liu
Journal:  Br J Nutr       Date:  2010-12-09       Impact factor: 3.718

5.  Proteomic profiling of human islets collected from frozen pancreata using laser capture microdissection.

Authors:  Lina Zhang; Giacomo Lanzoni; Matteo Battarra; Luca Inverardi; Qibin Zhang
Journal:  J Proteomics       Date:  2016-09-13       Impact factor: 4.044

6.  Diabetes-induced alteration of F4/80+ macrophages: a study in mice with streptozotocin-induced diabetes for a long term.

Authors:  Haixia Ma; Guangwei Liu; Wenjun Ding; You Wu; Lu Cai; Yong Zhao
Journal:  J Mol Med (Berl)       Date:  2008-01-30       Impact factor: 4.599

7.  Genetic control of non obese diabetic mice susceptibility to high-dose streptozotocin-induced diabetes.

Authors:  C Gonzalez; S Cuvellier; C Hue-Beauvais; M Lévi-Strauss
Journal:  Diabetologia       Date:  2003-07-15       Impact factor: 10.122

8.  Differential transcriptional expression of PPARalpha, PPARgamma1, and PPARgamma2 in the peritoneal macrophages and T-cell subsets of non-obese diabetic mice.

Authors:  Nik-Soriani Yaacob; Mohd Arifin Kaderi; Mohd-Nor Norazmi
Journal:  J Clin Immunol       Date:  2009-05-27       Impact factor: 8.317

9.  Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice.

Authors:  Felix J Baker; Mark Lee; Yueh-hsiu Chien; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

10.  Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: relationship to invasive insulitis.

Authors:  G J Taborsky; Q Mei; D J Hackney; D P Figlewicz; R LeBoeuf; T O Mundinger
Journal:  Diabetologia       Date:  2009-10-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.